Novo Nordisk plans to launch an oral version of its highly successful weight loss medication, Wegovy (semaglutide), pending approval from the United States Food and Drug...
FluidAI Medical has achieved a significant milestone by obtaining clearance from the United States Food and Drug Administration (FDA) for its innovative device designed to predict...